- Home
- CCK vs QGEN Comparison
CCK vs QGEN Comparison
Compare CCK & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCK
- QGEN
- Stock Information
- Founded
- CCK 1906
- QGEN 1986
- Country
- CCK United States
- QGEN Netherlands
- Employees
- CCK N/A
- QGEN N/A
- Industry
- CCK Containers/Packaging
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCK Industrials
- QGEN Health Care
- Exchange
- CCK Nasdaq
- QGEN Nasdaq
- Market Cap
- CCK 10.4B
- QGEN 9.1B
- IPO Year
- CCK N/A
- QGEN 1996
- Fundamental
- Price
- CCK $85.14
- QGEN $40.71
- Analyst Decision
- CCK Strong Buy
- QGEN Buy
- Analyst Count
- CCK 13
- QGEN 9
- Target Price
- CCK $104.85
- QGEN $49.79
- AVG Volume (30 Days)
- CCK 1.4M
- QGEN 1.6M
- Earning Date
- CCK 04-28-2025
- QGEN 05-07-2025
- Dividend Yield
- CCK 1.22%
- QGEN 3.24%
- EPS Growth
- CCK N/A
- QGEN N/A
- EPS
- CCK 3.55
- QGEN 0.38
- Revenue
- CCK $11,801,000,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- CCK $2.52
- QGEN $4.74
- Revenue Next Year
- CCK $2.51
- QGEN $6.52
- P/E Ratio
- CCK $23.98
- QGEN $106.96
- Revenue Growth
- CCK N/A
- QGEN 0.66
- 52 Week Low
- CCK $70.84
- QGEN $37.63
- 52 Week High
- CCK $98.46
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- CCK 47.74
- QGEN 51.47
- Support Level
- CCK $83.51
- QGEN $38.97
- Resistance Level
- CCK $86.49
- QGEN $43.88
- Average True Range (ATR)
- CCK 3.40
- QGEN 1.53
- MACD
- CCK -0.03
- QGEN 0.18
- Stochastic Oscillator
- CCK 62.31
- QGEN 44.87
About CCK Crown Holdings Inc.
Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).